Target intelligence / Profile preview

B-cell receptor repertoire specific for rotavirus VP7 and VP4 P epitopes (BCR-RV-VP7/VP4)

Target
BCR-RV-VP7/VP4
Molecular classification
Receptor, Immunoglobulin, Other (Immune repertoire)
01

Overview

The B-cell receptor (BCR) repertoire specific for rotavirus VP7 and VP4 P epitopes refers to the diverse collection of immunoglobulins expressed by B cells that recognize the two primary neutralization antigens on the rotavirus outer capsid. VP7 is a glycoprotein (G-type) and VP4 is a protease-cleaved protein (P-type) that together mediate viral attachment and entry into host intestinal cells (Crawford et al., 2017, Nature Reviews Disease Primers). This repertoire is a critical component of the adaptive immune system's defense against rotavirus infection, as specific BCRs and their secreted antibody counterparts can neutralize the virus by blocking its ability to bind to cellular receptors or by preventing the conformational changes required for membrane penetration (Desselberger, 2014, Virus Research). Characterization of this repertoire is vital for understanding natural immunity and for the development of vaccines, such as Rotarix and RotaTeq, which aim to induce a robust and diverse population of these B cells (Angel et al., 2007, Journal of Infectious Diseases). Furthermore, identifying high-affinity BCR sequences from this repertoire allows for the engineering of monoclonal antibodies that can be used for passive immunization or as diagnostic tools (Nair et al., 2017, Journal of Virology).

Other names
Rotavirus-specific B-cell receptor repertoireAnti-VP7/VP4 antibody repertoireRotavirus-specific BCRsNeutralizing antibody repertoire against rotavirus
02

Mechanism of action

Neutralization of viral particles by binding to VP7 and VP4 proteins, thereby blocking viral attachment to host cell receptors and preventing membrane penetration.

03

Biological functions

Immune responseAntigen recognitionViral neutralizationAntibody production
04

Disease associations

Infection (Rotavirus gastroenteritis)
05

Safety considerations

Intussusception risk (associated with live-attenuated vaccines that stimulate this repertoire)Viral escape due to antigenic drift or shift in VP7/VP4 epitopesPotential for non-neutralizing antibodies to interfere with the immune response
06

Interacting drugs

Rotarix (Rotavirus vaccine, live, oral)

3 more in the full profile.

07

Biomarkers

Rotavirus-specific serum IgA titersVP7-specific B-cell frequencyVP4-specific B-cell frequencyPlasmablast counts following infection or vaccination

Beyond the preview

Go deeper on B-cell receptor repertoire specific for rotavirus VP7 and VP4 P epitopes (BCR-RV-VP7/VP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on B-cell receptor repertoire specific for rotavirus VP7 and VP4 P epitopes (BCR-RV-VP7/VP4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call